Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design - Wikidata - awgldk - TriplyDB

Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design

Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design

http://www.wikidata.org/entity/Q30043830

about

A review of malaria vaccine clinical projects based on the WHO rainbow table That Was Then But This Is Now: Malaria Research in the Time of an Eradication Agenda The role of research in viral disease eradication and elimination programs: lessons for malaria eradication Animal models for the study of HCV Development of humanized mouse models to study human malaria parasite infection Vaccines for malaria: how close are we?Structural and biochemical characterization of Plasmodium falciparum 12 (Pf12) reveals a unique interdomain organization and the potential for an antiparallel arrangement with Pf41 In vivo CD8+ T cell dynamics in the liver of Plasmodium yoelii immunized and infected mice New horizons for studying human hepatotropic infections Structure of the Plasmodium 6-cysteine s48/45 domain Disruption of the Plasmodium falciparum liver-stage antigen-1 locus causes a differentiation defect in late liver-stage parasites The March Toward Malaria Vaccines Removal of heterologous sequences from Plasmodium falciparum mutants using FLPe-recombinase Biochemical and functional analysis of two Plasmodium falciparum blood-stage 6-cys proteins: P12 and P41 A novel Pfs38 protein complex on the surface of Plasmodium falciparum blood-stage merozoites AMA1 and MAEBL are important for Plasmodium falciparum sporozoite infection of the liver Malaria parasites target the hepatocyte receptor EphA2 for successful host infection Complete Plasmodium falciparum liver-stage development in liver-chimeric mice.Three members of the 6-cys protein family of Plasmodium play a role in gamete fertility The acute transcriptomic and proteomic response of HC-04 hepatoma cells to hepatocyte growth factor and its implications for Plasmodium falciparum sporozoite invasion.Genetically modified organisms and visceral leishmaniasis Multiplex, DNase-free one-step reverse transcription PCR for Plasmodium 18S rRNA and spliced gametocyte-specific mRNAs.Engineering of Genetically Arrested Parasites (GAPs) For a Precision Malaria Vaccine Plasmodium P36 determines host cell receptor usage during sporozoite invasion A research agenda for malaria eradication: basic science and enabling technologies Minimal role for the circumsporozoite protein in the induction of sterile immunity by vaccination with live rodent malaria sporozoites Malaria gametocytogenesis.Identification of pre-erythrocytic malaria antigens that target hepatocytes for killing in vivo and contribute to protection elicited by whole-parasite vaccination.An update on the rapid advances in malaria parasite cell biology.Protection from experimental cerebral malaria with a single dose of radiation-attenuated, blood-stage Plasmodium berghei parasites.Knockout of the dhfr-ts gene in Trypanosoma cruzi generates attenuated parasites able to confer protection against a virulent challenge.Advances and challenges in malaria vaccine development.Plasmodium berghei Δp52&p36 parasites develop independent of a parasitophorous vacuole membrane in Huh-7 liver cells Malaria Parasite Liver Infection and Exoerythrocytic Biology.A genetically attenuated malaria vaccine candidate based on P. falciparum b9/slarp gene-deficient sporozoites Plasmodium Cysteine Repeat Modular Proteins 3 and 4 are essential for malaria parasite transmission from the mosquito to the host.Malaria parasite-synthesized heme is essential in the mosquito and liver stages and complements host heme in the blood stages of infection Malaria Vaccine Development: Are Bacterial Flagellin Fusion Proteins the Bridge between Mouse and Humans?Superior antimalarial immunity after vaccination with late liver stage-arresting genetically attenuated parasites A monoallelic deletion of the TcCRT gene increases the attenuation of a cultured Trypanosoma cruzi strain, protecting against an in vivo virulent challenge.

P2860

5eda0b53a3c370bd014c28c97406da583325ed09 98d24c7c19c16812975e14c4e170492f8ad2181d a35158e0946fb43626fd6cabcf4da325901360ec e0286e038fd9915b43cdbaf97283fd166f7c4f01 e3fe4c5bd3b58c03bc32da30b50415bea80b3cfa

P248

Q21034112-971C7C76-F574-4BF0-BDBE-C1A04BC54A0E Q22061808-41CC8DC0-A32E-43A6-860B-5AC38C1EA099 Q26700366-DFF91DA6-129B-42CC-99B6-FEE5B4FD4754 Q26797836-451E6235-D676-4C52-A93A-D36547088181 Q26851983-F06B02B6-C3A9-44CD-A41C-8C2FA11365F2 Q27024344-20260602-4E82-430E-8195-FCE9CEF689D3 Q27230051-90A92BAE-31C6-471C-A5AC-D681C689DF89 Q27310073-E4EDBADF-1C7F-40A5-B427-FCC4875FC655 Q27490975-A386D8D9-CF49-4665-B8E9-00FB4151CEEC Q27678432-36BF17EF-D854-4044-82D0-F23D39761971 Q27974558-96A08FB3-2C04-4BB3-BB2D-60521121CB0F Q28084325-094CC995-555F-4DDB-9268-0DA6BD995EDB Q28476396-986197FC-C91C-4B1C-975D-5AC537EDB2AD Q28481599-511831FA-F356-45EC-BBF9-C1EC4FC44BD3 Q30038987-AFAED0D6-623B-4180-AC68-97D1CF447097 Q30044955-AA9E23C9-3E45-4821-9925-A8003E1368D7 Q30047034-A75B5519-5D61-4465-B828-BE2334CA4344 Q30525395-89AC48C2-CF0B-4A42-BEB9-17EA6C030DCC Q33553363-0B2FB095-54AF-4659-9D4B-861CF343BBFC Q33583133-70A9E132-D7EF-40DB-A533-6A94E5D59346 Q33647026-D4C90097-0A82-47A2-AF62-A220DA9B2D90 Q33709137-C9DA2AC2-D4DC-4649-8F05-0D7F70030CF2 Q33744460-81EC49DA-037C-494B-8528-9BA2FA48D251 Q33798033-5201622F-D0C6-4AAA-AE95-4542A8C03C4A Q33818036-CD4540A3-C5DB-490B-97B2-AC2C4812CBC4 Q33826130-6D686AE6-0C4C-4EA4-8534-D1A29E050DCB Q33894262-311BF366-12D6-4F79-B73F-7905C3DE5E83 Q33905005-7EB0D803-0EFB-4D6C-A16B-3CE752303784 Q33905946-A21B738C-5A3C-4F29-A5F6-3126E2E7EF3C Q34026083-5FD4F815-0FA1-4C17-B596-5E5BE8539CCD Q34105267-9D4E9917-1712-45A7-B7D5-2D75C5803419 Q34145333-900EFC35-087B-46DF-A17F-8B107FD1D48B Q34507085-1B0567F0-D1AC-4D7F-B971-700F1B9C771F Q34552223-18CB103B-2CE5-499A-A3D9-E0786F3A234A Q34753532-630E2029-CFB1-438B-BD23-9B4913F04AC0 Q34871838-237EDD1B-C92F-4F3F-AB0A-F36D632FE535 Q34916854-AB5A1506-1359-4745-8B21-F8C2EF30FEF7 Q34983659-158D69A4-A866-46FC-BEEB-F04695CDD413 Q35051549-6031E566-8067-4ED5-986E-BCBD0E4FE219 Q35097813-12B76B9C-C458-481D-B1AA-8675FF65780A

P2860

Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design

http://www.wikidata.org/entity/Q30043830

description

2009 nî lūn-bûn

@nan

2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design

@ast

Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design

@en

type

label

Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design

@ast

Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design

@en

prefLabel

Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design

@ast

Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design

@en

P1433

Q30043830-0BB63F35-AE77-47C4-8BF2-AD04BBE1850F

P1476

Q30043830-31AF908F-2D4F-43CD-9262-D5BBA5A9367E

P2093

Q30043830-17E6DBA7-4E1C-42A4-AF33-9FF57C713CB0

Q30043830-4DC3141A-EE98-4FE9-B11D-3F1085EA22A5

Q30043830-61F5E73F-98BA-402D-A845-B31A8536D7FE

Q30043830-81F1F6C1-3AB3-4BFE-8F5B-3AD64F832B40

Q30043830-B3E6A6B2-B108-4BA0-AC34-B1665412001D

Q30043830-BB761E1C-709F-44E2-935E-C5FE7BC167C6

Q30043830-CC58911D-DEB1-442D-8102-78052C483AA3

Q30043830-D55C8F32-604D-46A4-A609-8ADD4C0C0126

Q30043830-DEA41EF0-2D28-40E1-8869-037ABA94FF8D

Q30043830-EA20AEA1-1E73-4E3C-BCD0-1E4EC27B7547

P2860

Q30043830-063EEFB8-51C8-45DF-8AED-130BC26A9573

Q30043830-09835538-2503-4891-979D-AEC049D276CE

Q30043830-0EEFA1C6-5B58-4858-B144-9441F52B7F6A

Q30043830-23665B79-D003-414A-AD92-B96B521BD032

Q30043830-2F0429AA-E106-4B9F-A37C-677DF530B8AC

Q30043830-3AAB4473-C947-4641-8AEE-5441754B02F3

Q30043830-3D6F2AFB-50C3-4395-94C3-E38EABEED608

Q30043830-49A74B8A-A1E9-4AAE-8ED5-E291A3833960

Q30043830-4DFC60E6-FA3C-42B5-A78A-29CF1C67832E

Q30043830-5049F4B0-5426-42A8-AFA7-3C1B7EF87ACA

P304

Q30043830-B89F4F1C-3A41-4B1A-BBCD-E5E204C61716

P31

Q30043830-8E5B867C-2160-4A7E-A864-6E388156C6C0

P3181

Q30043830-71A718AA-6168-4194-9601-68C485409315

P356

Q30043830-71EA89A7-5631-4429-84F1-EEB5C8830C07

P407

Q30043830-568F802D-778C-4E9A-9B9F-42ACC9219615

P433

Q30043830-301391B5-3891-4AEC-BFF4-D0A398AE302E

P478

Q30043830-B8E7BA4A-22DD-40B5-A62D-5E9F0333D93B

P50

Q30043830-6712E0E6-D54F-4D14-9183-C66C4537FA45

Q30043830-90FB6707-49FD-408B-B82E-70BAC734D8E9

Q30043830-CBBFD143-9E84-4C9C-99CD-4E6E1AD4E5D4

Q30043830-DAF1D1A3-B178-4D87-9BCB-FA4CF1D644FC

Q30043830-F9471CAA-6CE3-4BC4-8DE9-D0D3EA3CADAC

P577

Q30043830-41FF7522-A880-457A-A039-124290B40746

P5875

Q30043830-020FBEBE-F5EF-4ED0-8D13-BDE74A0FAB61

P698

Q30043830-61B383D5-3648-4014-A5E1-4BE68ABB2E94

P921

Q30043830-34D435D9-1C66-46AA-8219-F099C6A3690A

Q30043830-509833CA-2715-40AB-A98A-0EE991B87F15

Q30043830-5FE384C2-293B-4991-B090-4A7C59B70DF5

Q30043830-7B5A061C-4FC6-4E77-8095-D57D5CE1065C

Q30043830-94D0D575-1669-44A5-98C1-9656678A7E16

Q30043830-978AB428-C9C9-4FA8-B1AF-301F6418CFFE

Q30043830-C59CAA9E-E522-4315-9D41-9743E471A171

Q30043830-E0F1889B-7D8D-44A4-89CF-82D163157CDB

Q30043830-EC7018AD-A5B5-46ED-8CAD-041EE2125CD4

Q30043830-F19C9D18-EE50-49E3-938E-D5B2FDF1533A

P932

Q30043830-7D0B7C34-88DA-4453-B161-EA6360C417C5

P3181

P356

PNAS.0906387106

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design

@en

P2093

Ahmed S I Aly

http://www.w3.org/2001/XMLSchema#string

Brant A Murdock

http://www.w3.org/2001/XMLSchema#string

Donald G Heppner

http://www.w3.org/2001/XMLSchema#string

Jack Williams

http://www.w3.org/2001/XMLSchema#string

John B Sacci

http://www.w3.org/2001/XMLSchema#string

Kelley M VanBuskirk

http://www.w3.org/2001/XMLSchema#string

Matthew T O'Neill

http://www.w3.org/2001/XMLSchema#string

Megan G Dowler

http://www.w3.org/2001/XMLSchema#string

Niwat Kangwanrangsan

http://www.w3.org/2001/XMLSchema#string

Norman M Kneteman

http://www.w3.org/2001/XMLSchema#string

P2860

The global distribution of clinical episodes of Plasmodium falciparum malaria

Malaria: progress, perils, and prospects for eradication

Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites

Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial

Protective immunity produced by the injection of x-irradiated sporozoites of plasmodium berghei

Transformation with human dihydrofolate reductase renders malaria parasites insensitive to WR99210 but does not affect the intrinsic activity of proguanil

Hepatitis C virus replication in mice with chimeric human livers

An atypical mitogen-activated protein kinase controls cytokinesis and flagellar motility during male gamete formation in a malaria parasite

Two proteins with 6-cys motifs are required for malarial parasites to commit to infection of the hepatocyte

Exploring the transcriptome of the malaria sporozoite stage

P304

13004-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1191181

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.0906387106

http://www.w3.org/2001/XMLSchema#string

P407

P433

31

http://www.w3.org/2001/XMLSchema#string

P478

106

http://www.w3.org/2001/XMLSchema#string

P50

Alan Frederick Cowman

Alexander Maier

Sebastian A. Mikolajczak

Takafumi Tsuboi

Stefan H I Kappe

P577

2009-08-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26689071

http://www.w3.org/2001/XMLSchema#string

P698

19625622

http://www.w3.org/2001/XMLSchema#string

P921

attenuated vaccine

Plasmodium falciparum

6-cysteine protein P52

6-cysteine protein P52, putative

6-cysteine protein P52, putative

6-cysteine protein P52, putative

6-cysteine protein P52, putative

6-cysteine protein P52, putative

6-cysteine protein P52, putative

6-cysteine protein P52, putative

P932

2714279

http://www.w3.org/2001/XMLSchema#string